LAWRENCE SELLIN: How China Uses U.S. Taxpayer Dollars to Fund its Biowarfare Program | Joe Hoft

News

Get The Latest

News

Get The Latest

LAWRENCE SELLIN: How China Uses U.S. Taxpayer Dollars to Fund its Biowarfare Program

How China uses U.S. taxpayer dollars to fund its biowarfare program.

Guest post from Lawrence Sellin – see also Chinese Fifth Column News at Substack especially if you would like to check the numbered citations below. 

There are many examples of Chinese scientists working in the United States, who have received U.S. taxpayer-funded research grants, collectively worth billions of dollars, but have maintained active collaboration with People’s Liberation Army (PLA) scientists.

Through clever manipulation of scientific exchange programs with the U.S. and exploitation of the legal U.S. immigration, China has successfully “colonized” U.S. research centers and made them de facto extensions of its fused military-civilian research and development programs.

What follows is one example. It involves three key PLA-trained Chinese scientists and their associates in a partnership that started thirty years ago, which eventually contributed to the laboratory synthesis of the COVID-19 virus.

In a process I call “scientific chain migration,” a Chinese scientist, loyal to the Chinese Communist Party, establishes himself in a U.S. research center, obtains millions of dollars of U.S. taxpayer-funded research grants, all while maintaining scientific collaboration with PLA institutions and training other PLA-linked scientists in his U.S. laboratory.

Yusen Zhou, who was the Beijing anchor of the PLA partnership and now deceased under mysterious circumstances (89), worked in the State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China.

Shibo Jiang, who was the U.S. anchor of the PLA partnership, obtained his M.S. and M.D. degrees from the PLA’s First and Fourth Medical University, respectively. From 1987 to 1990, he was a postdoctoral fellow in the Laboratory of Cellular Physiology and Immunology at the Rockefeller University in New York. From 1990 to 2010, he worked in the Lindsley F. Kimball Research Institute of the New York Blood Center as Assistant Member, Associate Member, Member, and then Head of the Viral Immunology Laboratory (90). According to his published biography, Shibo Jiang became a professor at Shanghai’s Fudan University in 2010 (91), but maintained an unclear affiliation with the Lindsley F. Kimball Research Institute, seemingly to obtain additional U.S. government funding. Shibo Jiang also trained numerous PLA-linked and other Chinese scientists in his New York laboratory.

Between 1997 and 2018, Shibo Jiang was awarded U.S. research grants amounting to more than $17 million, the vast majority of which came from Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) (92). During that time, he was also receiving funding from the Chinese government and actively collaborating with Chinese research institutions including those of the PLA.

Lanying Du, allegedly Yusen Zhou’s wife (93), represented the second wave of PLA-trained scientists in the process of “scientific chain migration.” She was trained at the Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (94) and in 2007 (95) joined Shibo Jiang’s laboratory at Lindsley F. Kimball Research Institute in New York. While Shibo Jiang eventually returned to China, Lanying Du remained in the U.S. training the third and fourth wave of Chinese scientists. In 2021, she was appointed Distinguished University Professor in the Institute for Biomedical Sciences at Georgia State University, which houses one of the few high containment Biosafety Level-4 facilities in the U.S. capable of handling the world’s most dangerous viruses.

Between 2011 and 2023, Lanying Du received over $18 million in U.S. research grants all of which came from Anthony Fauci’s NIAID (92). During that time, she was actively collaborating with Chinese research institutions including those of the PLA.

Although disturbing in themselves, the following describes only some of the collaborative research activities of PLA scientist Yusen Zhou and PLA-trained scientists Shibo Jiang and Lanying Du, while the latter two were funded by U.S. taxpayers.

In 2004, while working at the Lindsley F. Kimball Research Institute in New York and being funded by Fauci’s NIAID for HIV research (92), Shibo Jiang, nevertheless, began an intensive 16-year research collaboration on coronaviruses, influenza and other viruses with Yusen Zhou of the Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, studies which included the participation of Lanying Du, who was also funded by NIAID (92).

Coronavirus research described in 2004-2007 scientific articles (96-100) published by Shibo Jiang together with Yusen Zhou and Lanying Du, both of whom were working at the Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences at the time, was done in parallel with research funded by NIAID, the results from which were not reported to NIAID (92).

In 2007, at the same time Shibo Jiang was conducting collaborative research on coronaviruses with PLA scientists, he was working with the Virology Department at the U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick, Maryland (101), research that was also unreported to NIAID.

Also in 2007, Shibo Jiang was awarded a four-year $1,453,903 grant, R01AI068002, from NIAID to study coronavirus vaccines (92).

According to the National Institutes of Health database (92), Shibo Jiang reported 13 scientific publications resulting from the R01AI068002 grant. All the studies were conducted with Langyin Du and 9 of which involved collaborations between Shibo Jiang and PLA institutions for projects that were jointly funded by both NIAID and the PLA.

During the four years the R01AI068002 grant was active, Shibo Jiang published at least 8 scientific articles with PLA institutions, funded by China, that were not reported to NIAID.

Six of those scientific publications were co-authored by Lanying Du and Yusen Zhou (102-107), while two of the studies were done with PLA-trained Shuwen Liu from the First Medical University of the PLA in Guangzhou, now known as Southern Medical University (108,109).

Shibo Jiang and Shuwen Liu first worked together at the PLA’s First Military Medical University, where they published an article on the human immunodeficiency virus (HIV) in 1986 (110).

By 2002, Shuwen Liu from the PLA’s First Military Medical University, joined Shibo Jiang at the Lindsley F. Kimball Research Institute. Together, they published a scientific article with PLA scientists at the First Military Medical University that was funded by NIAID grant R01AI46221 (111).

In 2010, Shibo Jiang was appointed a professor at Fudan University in Shanghai, but maintained an unclear relationship with the Lindsley F. Kimball Research Institute in New York. It was through that relationship that Shibo Jiang, from 2012 to 2018, became a Principal Investigator on two additional NIAID research grants with Peter J. Hotez of Baylor College of Medicine, R01AI098775 “RBD recombinant protein-based SARS vaccine for biodefense” for $6,057,973, and with Sara Lustigman of the Lindsley F. Kimball Research Institute, U01AI124260 “Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination” for $1,413,272 (92).

In 2011, Lanying Du, who had joined Shibo Jiang at the Lindsley F. Kimball Research Institute on 2007 and remained there when he became a professor at Fudan University in 2010, received her first of many NIAID research grants, which, as of today, amounts to over $18 million. In 2021, Lanying Du moved to Georgia State University, where she continues to receive NIAID funding (92).

Between 2012 and 2018, when both were funded by NIAID, Shibo Jiang and Lanying Du published over 30 articles with PLA scientist Yusen Zhou studying variety of viruses including coronaviruses, influenza, Zika virus, Hepatitis B Virus and Porcine Epidemic Diarrhea Coronavirus (112-142). Collaborative research was also conducted with other PLA or PLA-linked scientists like Guangyu Zhao (142), Wanbo Tai (142), Chengfeng Qin (143) and the “bat woman” Zhengli Shi of the Wuhan Institute of Virology (144,145).

Many of the studies done by Shibo Jiang and Lanying Du with PLA institutions occurred outside of the parameters of their NIAID grants and were unreported to NIAID.

For example, in 2015, while receiving funding from NIAID, Shibo Jiang and Lanying Du published an article with Yusen Zhou and other PLA scientists related to what could be described as race-based therapeutics, developing vaccines specifically designed to benefit Chinese populations (146).

The collaboration between PLA scientist Yusen Zhou and PLA-trained scientists Shibo Jiang and Lanying Du ended with Zhou’s mysterious death in May, 2020.

Nevertheless, the manipulation of scientific exchange programs, the exploitation of the legal U.S. immigration and the misuse of U.S. taxpayer-funded research funds, both by Chinese scientists working in the United States and by American scientists collaborating with scientists in China, continues.

 

Leave a Comment